The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-chloro-N-(2-(3,5-dichloro-2-hydroxyphenyl)-1H-benzo[d]imidazol-5-yl)benzamide ID: ALA386447
PubChem CID: 136043861
Max Phase: Preclinical
Molecular Formula: C20H12Cl3N3O2
Molecular Weight: 432.69
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1ccc2[nH]c(-c3cc(Cl)cc(Cl)c3O)nc2c1)c1ccccc1Cl
Standard InChI: InChI=1S/C20H12Cl3N3O2/c21-10-7-13(18(27)15(23)8-10)19-25-16-6-5-11(9-17(16)26-19)24-20(28)12-3-1-2-4-14(12)22/h1-9,27H,(H,24,28)(H,25,26)
Standard InChI Key: CVOZHNOLAFROBK-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
1.4767 -7.4346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8775 -8.1547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7017 -8.1666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1249 -7.4574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7180 -6.7348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8952 -6.7265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4544 -8.8629 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.6517 -7.4240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.6181 -5.7958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.6193 -6.6232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9044 -7.0360 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1880 -6.6227 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1909 -5.7922 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9062 -5.3830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4729 -7.0341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4716 -7.8591 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.7591 -6.6204 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.0439 -7.0318 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0473 -7.8553 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3330 -8.2666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3370 -6.6160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1619 -6.7632 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6222 -7.0236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6157 -7.8504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1733 -8.0984 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.9046 -7.8610 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.1038 -8.8869 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.1379 -6.0247 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
14 9 2 0
2 7 1 0
12 15 1 0
3 4 1 0
15 16 2 0
1 8 1 0
15 17 1 0
17 18 1 0
4 5 2 0
18 19 2 0
9 10 1 0
19 20 1 0
20 24 2 0
2 3 2 0
23 21 2 0
21 18 1 0
23 24 1 0
10 11 2 0
5 6 1 0
11 12 1 0
6 1 2 0
22 23 1 0
24 25 1 0
25 8 1 0
8 22 2 0
12 13 2 0
11 26 1 0
1 2 1 0
3 27 1 0
13 14 1 0
5 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 432.69Molecular Weight (Monoisotopic): 430.9995AlogP: 6.15#Rotatable Bonds: 3Polar Surface Area: 78.01Molecular Species: NEUTRALHBA: 3HBD: 3#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 6.71CX Basic pKa: 4.75CX LogP: 5.76CX LogD: 5.10Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.36Np Likeness Score: -1.48
References 1. Wolkenberg SE, Zhao Z, Kapitskaya M, Webber AL, Petrukhin K, Tang YS, Dean DC, Hartman GD, Lindsley CW.. (2006) Identification of potent agonists of photoreceptor-specific nuclear receptor (NR2E3) and preparation of a radioligand., 16 (19): [PMID:16879962 ] [10.1016/j.bmcl.2006.07.056 ]